Searched for
ASTRAZENECA SAFETY
From diapers to drugs: How India's global corporate hubs are putting AI to workHeads of several Global Capability Centres (GCCs) told Reuters they are deploying AI across a host of functions - from marketing and conten...- AstraZeneca India plans to sell 64-acre Bengaluru site for Rs 3,400 croreThe land parcel, expected to fetch about ₹3,400 crore for AstraZeneca Pharma India, has drawn interest from developers including the Sattva...
- Bollywood celebs express concern over Covishield vaccine's side effects: What they saidAstraZeneca's recent disclosure about Covishield's rare but serious side effects has sparked concerns among both medical professionals and ...
- Covishield Vaccine Case: AstraZeneca expresses 'sympathy' for those who lost loved onesCovishield Vaccine Row: Following AstraZeneca's acknowledgment of a rare side effect associated with its COVID-19 vaccine, known as Covishi...
- AstraZeneca acknowledges its covid vaccine, Covishield, can lead to rare blood clot side effects; Here's what we knowCovishield Covid Vaccine: The Covishield COVID-19 vaccine, developed by AstraZeneca in partnership with the University of Oxford, has been ...
- RDIF says early results of 'mix & match' of Sputnik Light, AstraZeneca jab found to be safeAstraZeneca COVID vaccine is the same as Covishield which is used in India and several other countries.
- AstraZeneca hits snag in Covid drug developmentThe drug, made from a combination of two antibodies, failed its main goal to treat Covid-19 symptoms in exposed patients, AstraZeneca said ...
- US will share AstraZeneca vaccines with the worldThe move greatly expands on the Biden administration's action last month to share about 4 million doses of the Covid vaccine with Mexico an...
- AstraZeneca shot is good if safety issues can be overcome: US top disease expert Anthony Fauci"Whether or not we ever use AZ is unclear but it looks right now at this point in time that we will not need it. It's not a negative indict...
- European Medicines Agency confirms clots as 'very rare' AstraZeneca side effectNo specific risk factors, including age, have been identified for thrombosis with the AstraZeneca shot, which could stem from an immune res...
- AstraZeneca to hasten trial update after US calls results outdatedThe UK drugmaker will “immediately engage” with the independent panel monitoring the trial to share the latest efficacy information, AstraZ...
- WHO gives nod to AstraZeneca vaccine and its 'tremendous potential'"The AstraZeneca COVID-19 vaccine (including Covishield) continues to have a positive benefit-risk profile, with tremendous potential to pr...
- WHO vaccine safety panel to issue findings on AstraZeneca on FridayThe WHO's global advisory committee on vaccine safety examined the data on Tuesday and reviewed reports of rare blood coagulation disorders...
- Key questions as EU watchdog rules on AstraZenecaThe EMA is the regulator for all human and animal medicines in the 27 nations of the European Union plus the European Economic Area countri...
- WHO reviewing data, recommends AstraZeneca Covid jabs continue"The WHO Global Advisory Committee on Vaccine Safety is carefully assessing the latest available safety data," the UN health agency said in...
- India says it has no concern about AstraZeneca vaccine side effectsThe safety committee was also looking at "serious thromboembolic events" from the UK. Sweden and Latvia on Tuesday joined Spain, Germany, F...
- AstraZeneca Pharma surges 13% as parent resumes phase 3 vaccine trials in UKThe Serum Institute of India said it would restart its trials once it had permission from the Drugs Controller General of India, Reuters re...
- Serum Institute of India officially halts the trial of Astrazeneca-Oxford vaccine in India"We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials. We are following DCGI's instructions and wil...
- Biopharma giant AstraZeneca begins coronavirus dual-use antibody drug trial in UKThe drug known as AZD7442 has the potential to be given as a preventative option for people exposed to the coronavirus, and to treat and pr...
- AstraZeneca to invest $90 million in India over next 5 yearsThe announcement follows the signing of a bilateral innovation partnership for a sustainable future between Sweden and India.
Load More
